ELN and myeloproliferative neoplasm: JAK2V617F mutation only in vascular cells did not induce myeloproliferative neoplasm (Supplementary Fig. 4B) and did not induce elastin degradation (Supplementary Fig. 4D) or aortic dilation (Supplementary Fig. 4C).